Literature DB >> 29542317

Developing Plasmodium vivax Resources for Liver Stage Study in the Peruvian Amazon Region.

Pamela Orjuela-Sanchez1, Zaira Hellen Villa2, Marta Moreno3, Carlos Tong-Rios2, Stephan Meister1, Gregory M LaMonte1, Brice Campo4, Joseph M Vinetz2,3,5, Elizabeth A Winzeler1.   

Abstract

To develop new drugs and vaccines for malaria elimination, it will be necessary to discover biological interventions, including small molecules that act against Plasmodium vivax exoerythrocytic forms. However, a robust in vitro culture system for P. vivax is still lacking. Thus, to study exoerythrocytic forms, researchers must have simultaneous access to fresh, temperature-controlled patient blood samples, as well as an anopheline mosquito colony. In addition, researchers must rely on native mosquito species to avoid introducing a potentially dangerous invasive species into a malaria-endemic region. Here, we report an in vitro culture system carried out on site in a malaria-endemic region for liver stage parasites of P. vivax sporozoites obtained from An. darlingi, the main malaria vector in the Americas. P. vivax sporozoites were obtained by dissection of salivary glands from infected An. darlingi mosquitoes and purified by Accudenz density gradient centrifugation. HC04 liver cells were exposed to P. vivax sporozoites and cultured up to 9 days. To overcome low P. vivax patient parasitemias, potentially lower mosquito vectorial capacity, and humid, nonsterile environmental conditions, a new antibiotic cocktail was included in tissue culture to prevent contamination. Culturing conditions supported exoerythrocytic (EEF) P. vivax liver stage growth up to 9 days and allowed for maturation into intrahepatocyte merosomes. Some of the identified small forms were resistant to atovaquone (1 μM) but sensitive to the phosphatidylinositol 4-kinase inhibitor, KDU691 (1 μM). This study reports a field-accessible EEF production process for drug discovery in a malaria-endemic site in which viable P. vivax sporozoites are used for drug studies using hepatocyte infection. Our data demonstrate that the development of meaningful, field-based resources for P. vivax liver stage drug screening and liver stage human malaria experimentation in the Amazon region is feasible.

Entities:  

Keywords:  Anopheles darlingi; Peruvian Amazon region; Plasmodium vivax; drug evaluation; exoerythrocytic stage; in vitro culture; sporozoite

Mesh:

Year:  2018        PMID: 29542317     DOI: 10.1021/acsinfecdis.7b00198

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  5 in total

1.  Vancomycin improves Plasmodium yoelii malaria parasite in vitro liver stage cultures by controlling Elizabethkingia anophelis, a bacterium in the microbiome of lab-reared Anopheles mosquitoes.

Authors:  Melanie J Shears; Sean C Murphy
Journal:  Mol Biochem Parasitol       Date:  2020-04-30       Impact factor: 1.759

2.  Continuous Supply of Plasmodium vivax Sporozoites from Colonized Anopheles darlingi in the Peruvian Amazon.

Authors:  Marta Moreno; Carlos Tong-Rios; Pamela Orjuela-Sanchez; Gabriel Carrasco-Escobar; Brice Campo; Dionicia Gamboa; Elizabeth A Winzeler; Joseph M Vinetz
Journal:  ACS Infect Dis       Date:  2018-03-15       Impact factor: 5.084

3.  Plasmodium vivax liver stage assay platforms using Indian clinical isolates.

Authors:  Pradeep A Subramani; Neha Vartak-Sharma; Seetha Sreekumar; Pallavi Mathur; Bhavana Nayer; Sushrut Dakhore; Sowmya K Basavanna; Devaiah M Kalappa; Ramya V Krishnamurthy; Benudhar Mukhi; Priyasha Mishra; Noriko Yoshida; Susanta Kumar Ghosh; Radhakrishan Shandil; Shridhar Narayanan; Brice Campo; Kouichi Hasegawa; Anupkumar R Anvikar; Neena Valecha; Varadharajan Sundaramurthy
Journal:  Malar J       Date:  2020-06-22       Impact factor: 2.979

4.  Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3.

Authors:  Dora Posfai; Steven P Maher; Camille Roesch; Amélie Vantaux; Kayla Sylvester; Julie Péneau; Jean Popovici; Dennis E Kyle; Benoît Witkowski; Emily R Derbyshire
Journal:  Cell Chem Biol       Date:  2020-04-23       Impact factor: 8.116

5.  Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection.

Authors:  Gregory M LaMonte; Pamela Orjuela-Sanchez; Jaeson Calla; Lawrence T Wang; Shangzhong Li; Justine Swann; Annie N Cowell; Bing Yu Zou; Alyaa M Abdel-Haleem Mohamed; Zaira Hellen Villa Galarce; Marta Moreno; Carlos Tong Rios; Joseph M Vinetz; Nathan Lewis; Elizabeth A Winzeler
Journal:  Nat Commun       Date:  2019-01-30       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.